Requires unrestricted Medicaid coverage for ovulation enhancing drugs and medical services related to administering such drugs for certain beneficiaries experiencing infertility.
Received in the Senate Referred to SHH
Email me when A 1207 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track A 1207. By continuing you agree to the Terms and Privacy Policy.
Legislative status
- Introduced
- In Committee
- Reported by Committee
- Floor Vote Scheduled
- Passed One Chamber
- Passed Both Chambers
- Sent to Executive
- Signed into Law
Summary
The bill adds a Medicaid benefit that pays for ovulation‑enhancing medication and the associated office visits, hysterosalpingograms, pelvic ultrasounds, and blood tests for eligible adults aged 21 to 44 who have been diagnosed with infertility. Coverage is limited to three treatment cycles per beneficiary and only applies when federal Medicaid funding is available. It expands the state Medicaid plan without changing other eligibility rules.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about A 1207
3 free questions a day, no accountHearings
- General Assembly — SessionGeneral Assembly · Sep 24, 2026
- Appropriations — MeetingAppropriations · Jun 23, 2026
- Health — MeetingHealth · Jun 18, 2026
History
- Introduced, Referred to Assembly Health Committee
Sponsors
- Avi Schnall (D) · sponsor
- Bagolie, Rosaura
- Murphy, Carol A.
- Pintor Marin, Eliana
- Schaer, Gary S.
- Schnall, Alexander
- Venezia, Michael
Similar bills in other states
Loading the map of where bills like this one were filed.
Topics
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when A 1207 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track A 1207 freeOr ask your AI assistant about A 1207 directly:
Add to Claude, ChatGPT or Cursor